Last update 01 Nov 2024

NRC-2694

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [2]
Target
EGFR
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Squamous cell carcinoma of head and neck metastaticSquamous Cell Carcinoma
Inactive Indication
Breast Cancer
Originator Organization
Natco SA
Active Organization
Natco SANATCO Pharma Ltd.NATCO Pharma Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H26N4O3
InChIKeyWBKHQQZRHCECKK-UHFFFAOYSA-N
CAS Registry936446-61-6

Related

3
Clinical Trials associated with NRC-2694
NCT05283226 / RecruitingPhase 2
A Phase 2 Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
CTRI/2019/06/019649 / RecruitingPhase 2
A Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-A in patients with recurrent Head and Neck Squamous Cell Carcinoma
CTRI/2014/01/004293 / CompletedPhase 1
A Phase I Clinical Study to evaluate the safety, pharmacokinetics and anti-tumor activity of NRC-2694-A in patients with advanced Solid Malignancies
100 Clinical Results associated with NRC-2694
Login to view more data
100 Translational Medicine associated with NRC-2694
Login to view more data
100 Patents (Medical) associated with NRC-2694
Login to view more data
100 Deals associated with NRC-2694
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous cell carcinoma of head and neck metastaticPhase 2
US
NATCO Pharma Ltd.NATCO Pharma Ltd.
30 Sep 2022
Squamous cell carcinoma of head and neck metastaticPhase 2
IN
NATCO Pharma Ltd.NATCO Pharma Ltd.
30 Sep 2022
Squamous Cell CarcinomaPhase 2-
Natco SA
-
Breast CancerPreclinical
IN
NATCO Pharma Ltd.NATCO Pharma Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free